Page last updated: 2024-09-05

sb 216763 and Disease Exacerbation

sb 216763 has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, DB; Jung, JH; Kang, SE; Kim, H; Kim, SH; Lee, H; Srivastava, SK; Yun, M1
Gao, JF; Huang, XY; Jing, SF; Li, CD; Wang, DZ; Wei, H1

Other Studies

2 other study(ies) available for sb 216763 and Disease Exacerbation

ArticleYear
Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.
    Oncogene, 2018, Volume: 37, Issue:27

    Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Cysteine Proteinase Inhibitors; Disease Progression; F-Box-WD Repeat-Containing Protein 7; G1 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Glycogen Synthase Kinase 3 beta; HCT116 Cells; HEK293 Cells; HT29 Cells; Humans; Indoles; Leupeptins; Male; Maleimides; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Phosphorylation; Proto-Oncogene Proteins c-myc; Repressor Proteins; RNA Interference; RNA, Small Interfering; Transplantation, Heterologous

2018
Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel.
    Drug research, 2015, Volume: 65, Issue:11

    Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Maleimides; Matrix Metalloproteinase 9; Osteosarcoma; Taxoids; Time Factors; Wnt Signaling Pathway

2015